Human trials showed that in people with high-risk features, treatment with minocycline reduced in 6 months the risk of conversion to MS, decreased lesion volume, and showed the absence of new enhancing lesions, but this effect did not last beyond 24 months of study (Preiningerova et al., 2022)
Bankkauffrau in Deutschland, Stock Broker in New York, Simultanbersetzerin fr einige Botschaften und Konsulate in Deutschland
doi: 10.3389/fphar.2020.572009 127 SzturmowiczMDemkowU
Glutathioneis the bodys Master Antioxidant. It is used by every cell in the human body, andits absolutely vital for immune health
Higher doses often cost more because they require additional glutathione, longer infusion times, and closer monitoring
This "brightening" effectdifferent from actual lighteningcomes from glutathione's ability to support cellular regeneration and reduce oxidative stress